Skip to main content

Table 1 Demographics and headache characteristics of the study population

From: Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial

 

Group A (n = 46)

Group B (n = 46)

Group C (n = 45)

Statistics

Sex n° (%)

   

NS§

F

39

37

34

M

7

9

11

Age mean ± SD (yrs)

44.9 ± 11

46.2 ± 12

46.3 ± 11.4

NS¤

(median)

(48)

(48)

(49)

Educational level n° (%)

    

Secondary school or above

30

31

27

NS§

Primary or middle school

16

15

18

Employed n°(%)

    

Yes

29

28

25

NS§

No

17

18

20

 

Marital status n° (%)

    

Single

8

7

5

NS§

Married

32

32

35

 

Widowed/divorced

6

7

5

Migraine subtype n° (%)

    

With aura

5

3

5

NS*

Without aura

41

43

40

 

Duration of migraine

    

mean±SD (yrs)

25.8 ± 12.8

26.0 ± 12

26.1 ± 11.7

NS¤

(median)

(29)

(29)

(30)

 

Duration of MOH

    

mean±SD (yrs)

3.3 ±3.3

2.9 ± 3.1

3.4 ± 2.9

NS¤

(3)

(2)

(3)

Number of headache days/month

    

mean±SD

24.9 ± 6

25.4 ± 6.7

25.4 ± 6.4

NS¤

(median)

(30)

(30)

(30)

 

Number of days with use of symptomatic medication/month

    

mean±SD

23.9 ± 5.4

24.1 ± 4.8

24.3 ± 4.9

NS¤

(median)

(30)

(30)

(30)

 

Overused drugs n (%):

   

NS*

· Analgesics

16

14

18

 

· Ergotamine

1

1

1

 

· NSAIDs in combination

10

11

10

· Combination of acute medications

6

6

6

· Triptans

13

14

10

Number of overused medications/month

   

NS¤

mean ±SD

37.2 ± 28.4

36.9 ± 32.4

38.2 ± 31

 

(median)

(38)

(38)

(40)

 
  1. NS = not significant, *Fisher’s test, § Chi-square test, ¤ Kruskal-Wallis test.